Sideroblastic anemia following treatment of chronic myeloid leukemia with busulfan.
Magalhães
S M
SM
Duarte
F B
FB
Ribeiro
S C
SC
Borovik
C L
CL
Lorand-Metze
I
I
D000368:Aged; D000756:Anemia, Sideroblastic / Q000139:chemically induced*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D002066:Busulfan / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*
D018906:Antineoplastic Agents, Alkylating; D002066:Busulfan